Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Donor-Derived Cell-free DNA in Association With Gene-Expression Profiling (AlloMap®) in Heart Transplant Recipients (D-OAR)

NCT02178943 is registered in ClinicalTrials.gov with CareDx as lead sponsor.

NCT NCT02178943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02178943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Donor-Derived Cell-free DNA in Association With Gene-Expression Profiling (AlloMap®) in Heart Transplant Recipients (D-OAR)
Lead sponsor
CareDx
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
February 29, 2020
Enrollment
100 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac transplant failure, cardiac transplant rejection, heart diseases